Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature

Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration‐resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yausep, Oliver E., Agarwal, Raksheeth, Aulina, Rifqha, Wijaya, Anthony E., Amaia, Ilonka, Moekti, Addina W., Rinaldi, Ikhwan, Hamid, Agus Rizal A. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692971/
https://www.ncbi.nlm.nih.gov/pubmed/31428397
http://dx.doi.org/10.1002/ccr3.2288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692971/
https://www.ncbi.nlm.nih.gov/pubmed/31428397
http://dx.doi.org/10.1002/ccr3.2288

Ejemplares similares